vs
Side-by-side financial comparison of ROCKWELL MEDICAL, INC. (RMTI) and Velo3D, Inc. (VELO). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($17.3M vs $9.4M, roughly 1.8× Velo3D, Inc.). ROCKWELL MEDICAL, INC. runs the higher net margin — -9.2% vs -231.9%, a 222.7% gap on every dollar of revenue. On growth, ROCKWELL MEDICAL, INC. posted the faster year-over-year revenue change (-8.5% vs -25.2%). Over the past eight quarters, Velo3D, Inc.'s revenue compounded faster (-1.8% CAGR vs -18.2%).
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
Velo3D, Inc. develops and sells advanced end-to-end metal additive manufacturing (3D printing) solutions, comprising industrial-grade printers, specialized processing software, and high-performance metal materials. It primarily serves global aerospace, defense, energy, semiconductor and industrial manufacturing markets, enabling customers to produce complex, high-precision metal parts that are difficult to manufacture with traditional methods.
RMTI vs VELO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.3M | $9.4M |
| Net Profit | $-1.6M | $-21.9M |
| Gross Margin | 16.8% | -73.6% |
| Operating Margin | — | -231.0% |
| Net Margin | -9.2% | -231.9% |
| Revenue YoY | -8.5% | -25.2% |
| Net Profit YoY | — | -2.9% |
| EPS (diluted) | $-0.04 | $-0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $17.3M | — | ||
| Q4 25 | $18.3M | $9.4M | ||
| Q3 25 | $15.9M | $13.6M | ||
| Q2 25 | $16.1M | $13.6M | ||
| Q1 25 | $18.9M | $9.3M | ||
| Q4 24 | $24.7M | $12.6M | ||
| Q3 24 | $28.3M | $8.2M | ||
| Q2 24 | $25.8M | $10.3M |
| Q1 26 | $-1.6M | — | ||
| Q4 25 | $-554.0K | $-21.9M | ||
| Q3 25 | $-1.8M | $-11.2M | ||
| Q2 25 | $-1.5M | $-13.3M | ||
| Q1 25 | $-1.5M | $-25.0M | ||
| Q4 24 | $-756.0K | $-21.3M | ||
| Q3 24 | $1.7M | $-21.9M | ||
| Q2 24 | $343.0K | $935.0K |
| Q1 26 | 16.8% | — | ||
| Q4 25 | 21.1% | -73.6% | ||
| Q3 25 | 14.3% | 3.2% | ||
| Q2 25 | 15.6% | -11.7% | ||
| Q1 25 | 16.1% | 7.5% | ||
| Q4 24 | 14.7% | -3.5% | ||
| Q3 24 | 22.0% | 49.4% | ||
| Q2 24 | 17.6% | -28.0% |
| Q1 26 | — | — | ||
| Q4 25 | -2.2% | -231.0% | ||
| Q3 25 | -9.9% | -73.3% | ||
| Q2 25 | -8.4% | -85.4% | ||
| Q1 25 | -7.2% | -123.6% | ||
| Q4 24 | -2.1% | -167.0% | ||
| Q3 24 | 6.8% | -213.8% | ||
| Q2 24 | 2.0% | -187.7% |
| Q1 26 | -9.2% | — | ||
| Q4 25 | -3.0% | -231.9% | ||
| Q3 25 | -11.0% | -82.0% | ||
| Q2 25 | -9.3% | -97.7% | ||
| Q1 25 | -8.0% | -268.4% | ||
| Q4 24 | -3.1% | -168.5% | ||
| Q3 24 | 5.9% | -265.3% | ||
| Q2 24 | 1.3% | 9.0% |
| Q1 26 | $-0.04 | — | ||
| Q4 25 | $-0.01 | $-0.87 | ||
| Q3 25 | $-0.05 | $-0.65 | ||
| Q2 25 | $-0.05 | $-0.94 | ||
| Q1 25 | $-0.04 | $-1.87 | ||
| Q4 24 | $-0.02 | $7.06 | ||
| Q3 24 | $0.04 | $-35.52 | ||
| Q2 24 | $0.01 | $1.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $39.0M |
| Total DebtLower is stronger | — | $31.0M |
| Stockholders' EquityBook value | $35.9M | $38.2M |
| Total Assets | $57.4M | $105.3M |
| Debt / EquityLower = less leverage | — | 0.81× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $10.7M | $39.0M | ||
| Q3 25 | $13.6M | $11.8M | ||
| Q2 25 | $12.5M | $854.0K | ||
| Q1 25 | $11.4M | $3.9M | ||
| Q4 24 | $15.7M | $1.2M | ||
| Q3 24 | $12.3M | $1.6M | ||
| Q2 24 | $11.9M | $3.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $31.0M | ||
| Q3 25 | — | $23.0M | ||
| Q2 25 | — | $22.5M | ||
| Q1 25 | — | $21.7M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $32.3M | ||
| Q2 24 | — | $33.5M |
| Q1 26 | $35.9M | — | ||
| Q4 25 | $37.0M | $38.2M | ||
| Q3 25 | $37.0M | $29.9M | ||
| Q2 25 | $30.4M | $21.4M | ||
| Q1 25 | $31.5M | $32.8M | ||
| Q4 24 | $32.6M | $39.7M | ||
| Q3 24 | $29.1M | $34.4M | ||
| Q2 24 | $23.5M | $52.1M |
| Q1 26 | $57.4M | — | ||
| Q4 25 | $57.1M | $105.3M | ||
| Q3 25 | $57.5M | $93.7M | ||
| Q2 25 | $52.6M | $78.4M | ||
| Q1 25 | $54.0M | $91.3M | ||
| Q4 24 | $59.2M | $89.2M | ||
| Q3 24 | $57.1M | $110.8M | ||
| Q2 24 | $53.0M | $116.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.81× | ||
| Q3 25 | — | 0.77× | ||
| Q2 25 | — | 1.05× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.94× | ||
| Q2 24 | — | 0.64× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-7.7M |
| Free Cash FlowOCF − Capex | — | $-8.3M |
| FCF MarginFCF / Revenue | — | -88.3% |
| Capex IntensityCapex / Revenue | — | 6.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $2.3M | $-7.7M | ||
| Q3 25 | $-1.3M | $-6.0M | ||
| Q2 25 | $1.8M | $-1.2M | ||
| Q1 25 | $-3.5M | $-12.3M | ||
| Q4 24 | $865.0K | $-2.2M | ||
| Q3 24 | $4.3M | $-2.0M | ||
| Q2 24 | $1.4M | $-8.0M |
| Q1 26 | — | — | ||
| Q4 25 | $2.2M | $-8.3M | ||
| Q3 25 | $-1.5M | $-6.3M | ||
| Q2 25 | $1.7M | $-3.0M | ||
| Q1 25 | $-3.5M | — | ||
| Q4 24 | $470.0K | $-2.2M | ||
| Q3 24 | $4.1M | $-2.0M | ||
| Q2 24 | $1.2M | $-8.0M |
| Q1 26 | — | — | ||
| Q4 25 | 12.0% | -88.3% | ||
| Q3 25 | -9.6% | -46.5% | ||
| Q2 25 | 10.5% | -22.2% | ||
| Q1 25 | -18.8% | — | ||
| Q4 24 | 1.9% | -17.7% | ||
| Q3 24 | 14.4% | -24.2% | ||
| Q2 24 | 4.5% | -77.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 6.4% | ||
| Q3 25 | 1.4% | 2.3% | ||
| Q2 25 | 1.0% | 13.3% | ||
| Q1 25 | 0.3% | 0.0% | ||
| Q4 24 | 1.6% | 0.2% | ||
| Q3 24 | 0.7% | 0.2% | ||
| Q2 24 | 1.1% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 4.20× | -8.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
